✦ LIBER ✦

HDAC Inhibitors as Targeted Treatment of Frontotemporal Lobar Degeneration

✍ Scribed by Rosse, Gerard

Book ID: 127076017
Publisher: American Chemical Society
Year: 2012
Tongue: English
Weight: 145 KB
Volume: 4
Category: Article
ISSN: 1948-5875
DOI: 10.1021/ml3003988

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of combination treatment of flu

Efficacy of combination treatment of fluvoxamine and tiapride for repetitive behaviors in frontotemporal lobar degeneration

✍ Yoshihiro MASAKI; Yoshitaka IKEJIRI; Takashi NISHIKAWA; Naoki HATTA; Hiroaki KAZ 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

P2-189: Longitudinal atrophy rate as a b

P2-189: Longitudinal atrophy rate as a biomarker of disease progression in frontotemporal lobar degeneration

✍ McNaught, Elizabeth; Rohrer, Jonathan D.; Omar, Rohani; Ahsan, Laila; Rossor, Ma 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 132 KB

IC-P2-116: Longitudinal atrophy rate as

IC-P2-116: Longitudinal atrophy rate as a biomarker of disease progression in frontotemporal lobar degeneration

✍ Elizabeth McNaught; Jonathan D. Rohrer; Rohani Omar; Laila Ahsan; Martin N. Ross 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Discovery of an orally active subtype-se

Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment

✍ Pan, De-Si; Yang, Qian-Jiao; Fu, Xin; Shan, Song; Zhu, Jing-Zhong; Zhang, Kun; L 📂 Article 📅 2014 🏛 The Royal Society of Chemistry 🌐 English ⚖ 841 KB

Characterization of SNARE Proteins in Hu

Characterization of SNARE Proteins in Human Pituitary Adenomas: Targeted Secretion Inhibitors as a New Strategy for the Treatment of Acromegaly?

✍ Garcia, Edwin A.; Trivellin, Giampaolo; Aflorei, Elena D.; Powell, Michael; Grie 📂 Article 📅 2013 🏛 Endocrine Society 🌐 English ⚖ 1000 KB

[Handbook of Experimental Pharmacology]

[Handbook of Experimental Pharmacology] Phosphodiesterases as Drug Targets Volume 204 || Phosphodiesterase Inhibitors in the Treatment of Inflammatory Diseases

✍ Francis, Sharron H.; Conti, Marco; Houslay, Miles D. 📂 Article 📅 2011 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 201 KB

Cyclic nucleotide phosphodiesterases (PDEs) are promising targets for pharmacological intervention. Multiple PDE genes, isoform diversity, selective expression and compartmentation of the isoforms, and an array of conformations of PDE proteins are properties that challenge development of drugs that